Optimizing antiseizure treatment in women of reproductive age and during pregnancy: Nationwide practice versus specialized epilepsy care in Poland.
文献摘要
Purpose To compare antiseizure medication (ASM) treatment patterns among women with epilepsy (WWE) of reproductive age and pregnant WWE using nationwide administrative data and a university epilepsy referral center cohort in Poland. Methods This retrospective study analyzed two complementary datasets. Nationwide data were obtained from the Polish National Health Fund, including 44,951 WWE aged 20-49 years in 2024 and 594 pregnant WWE who delivered in 2022. Referral center data were collected from medical records of 277 WWE aged 20-49 years treated in 2024 and 112 pregnancies managed between 2019 and 2026. Results Levetiracetam and lamotrigine were the most frequently prescribed ASMs in both cohorts. Compared with the nationwide population, women of reproductive age treated at the epilepsy center were significantly less likely to receive valproate (18.4 % vs. 31.1 %, p Conclusions Women managed at an epilepsy referral center were substantially less likely to receive potentially teratogenic ASMs, particularly valproate, despite representing a more clinically complex population. These findings highlight the contribution of specialized epilepsy care to optimizing pharmacological management for women of reproductive age and during pregnancy while supporting adherence to contemporary treatment recommendations.